Prodesse Gets FDA OK for H1N1 Claims for Assay | GenomeWeb

This article contains a clarification in the first graf regarding the claims for the ProFlu+ assay.

NEW YORK (GenomeWeb News) – Prodesse today said that the US Food and Drug Administration has cleared additional claims for the firm's ProFlu+ assay, which says that it correctly identifies as Influenza A positive specimens containing novel 2009 H1N1 influenza virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.